Riskpilot← Back to searchSign inGet full accessDantes AB
ABActiveOrg 5593996431Kyrkogatan 29 Våning 3General medical practice activities · NACE 8621Est. 20220 employees
Revenue 2024
SEK 286K
EBITDA margin
75.8%
Equity ratio
53.1%
Financial strength
Net profit 2024
SEK 136K
0 employees
| Revenue | SEK 286K | — |
| EBITDA | SEK 217K | — |
| Net profit | SEK 136K | — |
| Total assets | SEK 259K | — |
| Equity | SEK 137K | — |
| Employees | 0 | — |
Legal name
Dantes AB
Org number
5593996431
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
3 oktober 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva estetisk och medicinsk verksamhet inklusive injektionsbehandlingar, hårtransplantationer och läkarmottagning samt uthyrning av medicinsk personal. Bolaget ska även bedriva handel, import, export, agentur och teknisk representation inom säkerhets- och försvarsrelaterade produkter, optiska system, drönarteknik och övervakningsutrustning enligt gällande lagstiftning. Bolaget ska dessutom bedriva e-handel, konsultverksamhet samt odling av växter och därmed förenlig verksamhet.
Address
Kyrkogatan 29 Våning 3
Email
dantez.khezri@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | — | 286 |
| Staff expenses | — | −2 |
| EBITDA | 0 | 217 |
| Depreciation & amort. | — | — |
| EBIT | 0 | 217 |
| Net financials | — | 0 |
| Profit before tax | 0 | 167 |
| Tax | — | −31 |
| Net profit | — | 136 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | — | 259 |
| Equity | — | 137 |
| Long-term debt | — | — |
| Short-term debt | — | 71 |
| Total debt | — | 71 |
EBITDA margin
75.8%
This company
15.8%
Market median
+380% vs market
20232024
Equity ratio
53.1%
This company
38.2%
Market median
+39% vs market
20232024
Return on equity
98.7%
This company
18.4%
Market median
+436% vs market
20232024
Net profit margin
47.4%
This company
8.1%
Market median
+485% vs market
20232024
Asset turnover
1.11×
This company
1.12×
Market median
+1% vs market
20232024
Debt / equity
0.88×
This company
0.62×
Market median
+42% vs market
20232024
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dantes AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Zanyar Dan Khezri | Board of Directors | 0 companies |
| Shahla Ghaderi | Deputy Board Member | 0 companies |